Viewing Study NCT05600894


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2025-12-26 @ 12:05 AM
Study NCT ID: NCT05600894
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2022-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module